ScienceDaily: Top Health News |
- Designed antiviral proteins inhibit SARS-CoV-2 in the lab
- New tracking technology will help fight rhino poaching in Namibia
- Biological roots for teen risk-taking: Uneven brain growth
- Artificial intelligence aids gene activation discovery
- More cats might be COVID-19 positive than first believed, study suggests
- Cell-autonomous immunity shaped human evolution
- Metabolite signature of COVID-19 reveals multi-organ effects
- Bat tick found for the first time in New Jersey
- Gut microbiota not involved in the incidence of gestational diabetes mellitus
- Lecturer takes laptops and smart phones away and musters student presence
- Vitamin B1 deficiency a key factor in the development of alcohol-related dementia
- Lumpy proteins stiffen blood vessels of the brain
- Nature as a model: Researchers develop novel anti-inflammatory substance
- People who were children when their parents divorced have less 'love hormone'
- New glove-like device mimics sense of touch
- Mindfulness with paced breathing and lowering blood pressure
- Unlocking the mystery of tau for treatment of neurodegenerative diseases
- More than one drink a day may raise high blood pressure risk in adults with Type 2 diabetes
- Muscle aging: Stronger for longer
- Unconscious learning underlies belief in God, study suggests
- Insomnia identified as a new risk factor for type 2 diabetes in new study which also confirms many other risk and protective factors
- Cellular-level interactions that lead to the cytokine storm in COVID-19
- Lockdown did not reduce 'most harmful' type of air pollution in Scotland
- COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus
- Recharging N95 masks for continued usage
- Rare hyperinflammatory syndrome in children with COVID-19 described
- Could singing spread COVID-19?
- COVID-stress may be hard to beat even with exercise
Designed antiviral proteins inhibit SARS-CoV-2 in the lab Posted: 09 Sep 2020 11:03 AM PDT Computer-designed miniproteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19. The lead antiviral candidate rivals the best-known SARS-CoV-2 monoclonal antibodies in its protective actions. The synthetic antiviral candidates were designed to prevent infection by interfering with the mechanism that coronaviruses use to break into and enter cells. |
New tracking technology will help fight rhino poaching in Namibia Posted: 09 Sep 2020 09:40 AM PDT |
Biological roots for teen risk-taking: Uneven brain growth Posted: 09 Sep 2020 08:53 AM PDT Why do some adolescents take more risks than others? Research suggests that two centers in the brain, one which makes adolescents want to take risks and the other which prevents them from acting on these impulses, physically mature at different rates and that adolescents with large differences in the rate of development between these two brain regions are more likely to be risk-takers. |
Artificial intelligence aids gene activation discovery Posted: 09 Sep 2020 08:48 AM PDT Scientists have long known that human genes are activated through instructions delivered by the precise order of our DNA. With the aid of artificial intelligence, researchers have solved a long-standing DNA activation code mystery. Their discovery, which they termed the downstream core promoter region (DPR), could eventually be used to control gene activation in biotechnology and biomedical applications. |
More cats might be COVID-19 positive than first believed, study suggests Posted: 09 Sep 2020 08:48 AM PDT |
Cell-autonomous immunity shaped human evolution Posted: 09 Sep 2020 08:48 AM PDT Every human cell harbors its own defenses against microbial invaders, relying on strategies that date back to some of the earliest events in the history of life, researchers report. Because this 'cell-autonomous immunity' is so ancient and persistent, understanding it is essential to understanding human evolution and human medicine, the researchers said. |
Metabolite signature of COVID-19 reveals multi-organ effects Posted: 09 Sep 2020 08:48 AM PDT |
Bat tick found for the first time in New Jersey Posted: 09 Sep 2020 08:48 AM PDT |
Gut microbiota not involved in the incidence of gestational diabetes mellitus Posted: 09 Sep 2020 08:47 AM PDT |
Lecturer takes laptops and smart phones away and musters student presence Posted: 09 Sep 2020 07:02 AM PDT |
Vitamin B1 deficiency a key factor in the development of alcohol-related dementia Posted: 09 Sep 2020 07:02 AM PDT |
Lumpy proteins stiffen blood vessels of the brain Posted: 09 Sep 2020 07:02 AM PDT |
Nature as a model: Researchers develop novel anti-inflammatory substance Posted: 09 Sep 2020 07:02 AM PDT Anti-inflammatory substances based on components of human cells could one day improve treatment in patients. Researchers have developed a method for producing those substances with controlled quality. Since the body does not recognize them as foreign substances, they offer advantages over anti-inflammatory drugs such as ibuprofen or diclofenac. |
People who were children when their parents divorced have less 'love hormone' Posted: 09 Sep 2020 07:02 AM PDT People who were children when their parents were divorced showed lower levels of oxytocin -- the so-called 'love hormone' -- when they were adults than those whose parents remained married, according to a new study. The lower level may play a role in having trouble forming attachments when they are grown. |
New glove-like device mimics sense of touch Posted: 09 Sep 2020 07:02 AM PDT |
Mindfulness with paced breathing and lowering blood pressure Posted: 09 Sep 2020 07:02 AM PDT Now more than ever, Americans and people all over the world are under increased stress, which may adversely affect their health and well-being. Researchers explore the possibility that mindfulness with paced breathing reduces blood pressure. One of the most plausible mechanisms is that paced breathing stimulates the vagus nerve and parasympathetic nervous system, which reduce stress chemicals in the brain and increase vascular relaxation that may lead to lowering of blood pressure. |
Unlocking the mystery of tau for treatment of neurodegenerative diseases Posted: 09 Sep 2020 05:59 AM PDT |
More than one drink a day may raise high blood pressure risk in adults with Type 2 diabetes Posted: 09 Sep 2020 05:59 AM PDT |
Muscle aging: Stronger for longer Posted: 09 Sep 2020 05:59 AM PDT |
Unconscious learning underlies belief in God, study suggests Posted: 09 Sep 2020 05:59 AM PDT |
Posted: 08 Sep 2020 05:08 PM PDT A new study identifies insomnia as a risk factor associated with increased risk of developing type 2 diabetes (T2D). The study identifies 34 risk factors that are thought to increase (19) or decrease risk (15), as well as a further 21 'suggestive' risk factors where evidence was not quite as strong. |
Cellular-level interactions that lead to the cytokine storm in COVID-19 Posted: 08 Sep 2020 09:25 AM PDT |
Lockdown did not reduce 'most harmful' type of air pollution in Scotland Posted: 08 Sep 2020 09:25 AM PDT |
COVID-19 high-risk groups: Why the immune system is less effective at fighting the virus Posted: 08 Sep 2020 08:32 AM PDT Older people and people with underlying medical conditions are at particular risk of severe COVID-19. Researchers have discovered one possible reason for this vulnerability. While these risk groups produce greater quantities of an important type of immune cell known as 'T-helper cells', their T-helper cells show impaired function. This 'molecular brake' on the immune system could serve as a potential new treatment target in patients with severe COVID-19. |
Recharging N95 masks for continued usage Posted: 08 Sep 2020 08:32 AM PDT |
Rare hyperinflammatory syndrome in children with COVID-19 described Posted: 08 Sep 2020 07:16 AM PDT |
Could singing spread COVID-19? Posted: 08 Sep 2020 07:16 AM PDT |
COVID-stress may be hard to beat even with exercise Posted: 08 Sep 2020 06:15 AM PDT |
You are subscribed to email updates from Top Health News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |